ZA791635B - Thio etianic acid derivatives - Google Patents

Thio etianic acid derivatives

Info

Publication number
ZA791635B
ZA791635B ZA791635A ZA791635A ZA791635B ZA 791635 B ZA791635 B ZA 791635B ZA 791635 A ZA791635 A ZA 791635A ZA 791635 A ZA791635 A ZA 791635A ZA 791635 B ZA791635 B ZA 791635B
Authority
ZA
South Africa
Prior art keywords
thio
acid derivatives
etianic acid
etianic
derivatives
Prior art date
Application number
ZA791635A
Other languages
English (en)
Inventor
J Edwards
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ZA791635B publication Critical patent/ZA791635B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA791635A 1978-04-05 1979-04-05 Thio etianic acid derivatives ZA791635B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/893,388 US4188385A (en) 1978-04-05 1978-04-05 Thioetianic acid derivatives

Publications (1)

Publication Number Publication Date
ZA791635B true ZA791635B (en) 1980-11-26

Family

ID=25401484

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA791635A ZA791635B (en) 1978-04-05 1979-04-05 Thio etianic acid derivatives

Country Status (28)

Country Link
US (1) US4188385A (fr)
EP (1) EP0004741B1 (fr)
JP (2) JPS54141758A (fr)
AR (1) AR226035A1 (fr)
AT (1) AT368168B (fr)
AU (1) AU526025B2 (fr)
CA (1) CA1134345A (fr)
CS (1) CS203956B2 (fr)
DE (2) DE2960096D1 (fr)
DK (1) DK147735C (fr)
ES (1) ES479271A1 (fr)
FI (1) FI66393C (fr)
FR (1) FR2421912A1 (fr)
GB (1) GB2018256B (fr)
GR (1) GR67275B (fr)
HK (1) HK41284A (fr)
HU (1) HU179314B (fr)
IL (1) IL56972A0 (fr)
IT (1) IT1120954B (fr)
MY (1) MY8500575A (fr)
NO (1) NO152935C (fr)
NZ (1) NZ190076A (fr)
PL (1) PL121469B1 (fr)
PT (1) PT69409A (fr)
SG (1) SG6786G (fr)
SU (1) SU1052161A3 (fr)
YU (1) YU40929B (fr)
ZA (1) ZA791635B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
US4310466A (en) * 1979-08-31 1982-01-12 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
CA1201114A (fr) * 1980-02-15 1986-02-25 Gordon H. Phillipps Carbothioates d'androstane
NL191792C (nl) * 1980-02-15 1996-08-02 Glaxo Group Ltd Esters van een androstaan-17beta-carbothiozuur, werkwijze ter bereiding van deze esters, en farmaceutische preparaten, die deze esters bevatten.
US4578221A (en) * 1980-04-23 1986-03-25 Glaxo Group Limited Androstane carbothioic acids
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
GB9225923D0 (en) * 1992-12-11 1993-02-03 Rhone Poulenc Rorer Ltd New compositions of matter
CZ159195A3 (en) * 1992-12-24 1996-03-13 Rhone Poulenc Rorer Ltd Novel steroids, process of their preparation and pharmaceutical compositions containing thereof
BR9612309A (pt) * 1995-12-29 1999-07-13 Glaxo Group Ltd Composto uso de um composto composição farmacêutica formulação farmacêutica de aerossol combinação e processos para o tratamento de um indivíduo humano ou animal com uma condição anti-inflamatória e/ou alérgica e para a preparação de um composto
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
US20020133032A1 (en) * 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
GB0017988D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Novel process
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
AR032471A1 (es) * 2000-08-05 2003-11-12 Glaxo Group Ltd Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
CA2445839A1 (fr) * 2001-04-30 2002-11-07 Glaxo Group Limited Derives anti-inflammatoires d'androstane 17.beta.-carbothioate ester avec un groupe cyclique en position 17.alpha
US20040248867A1 (en) * 2001-06-12 2004-12-09 Keith Biggadike Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
IL150654A (en) 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate
WO2004087731A1 (fr) * 2003-04-04 2004-10-14 Alpharma Aps Methode de preparation de derives et d'intermediaires d'acides carbothioiques steroides
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
WO2009085879A2 (fr) * 2007-12-21 2009-07-09 Schering Corporation Agonistes du récepteur de glucocorticoïde substitués en c20-c21
JP2012530140A (ja) 2009-06-16 2012-11-29 メルク・シャープ・アンド・ドーム・コーポレーション グルココルチコイド受容体アゴニストとしての新規［３，２−ｃ］ヘテロアリールステロイド、組成物およびこの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2509171A (en) * 1946-02-06 1950-05-23 Ciba Ltd Primary alcohols from thiocarboxylic acids and esters
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
US3989686A (en) * 1972-06-15 1976-11-02 Glaxo Laboratories Limited Anaesthetic steroids of the androstane series and process for preparing same
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.

Also Published As

Publication number Publication date
MY8500575A (en) 1985-12-31
DK136579A (da) 1979-10-06
GB2018256A (en) 1979-10-17
IT1120954B (it) 1986-03-26
JPS54141758A (en) 1979-11-05
NO791140L (no) 1979-10-08
JPS6140648B2 (fr) 1986-09-10
US4188385A (en) 1980-02-12
NZ190076A (en) 1984-07-31
HK41284A (en) 1984-05-18
PT69409A (en) 1979-04-01
YU80379A (en) 1983-04-30
SG6786G (en) 1986-08-01
DK147735B (da) 1984-11-26
EP0004741A3 (en) 1979-11-14
FI66393C (fi) 1984-10-10
FI66393B (fi) 1984-06-29
GB2018256B (en) 1983-02-02
CS203956B2 (en) 1981-03-31
DE2960096D1 (en) 1981-03-19
EP0004741B1 (fr) 1981-01-28
CA1134345A (fr) 1982-10-26
JPS6069019A (ja) 1985-04-19
JPS611038B2 (fr) 1986-01-13
NO152935C (no) 1985-12-18
EP0004741A2 (fr) 1979-10-17
IL56972A0 (en) 1979-05-31
ATA251979A (de) 1982-01-15
AT368168B (de) 1982-09-27
AR226035A1 (es) 1982-05-31
FR2421912B1 (fr) 1981-03-20
AU526025B2 (en) 1982-12-16
YU40929B (en) 1986-08-31
FR2421912A1 (fr) 1979-11-02
IT7967652A0 (it) 1979-03-28
NO152935B (no) 1985-09-09
FI791081A (fi) 1979-10-06
HU179314B (en) 1982-09-28
PL214676A1 (fr) 1980-01-02
DK147735C (da) 1985-08-19
PL121469B1 (en) 1982-05-31
DE2912331A1 (de) 1979-10-18
AU4558379A (en) 1979-10-18
GR67275B (fr) 1981-06-26
SU1052161A3 (ru) 1983-10-30
ES479271A1 (es) 1980-01-16

Similar Documents

Publication Publication Date Title
GB2018256B (en) Thio atianic acid derivatives
ZA79989B (en) Phenoxyalkylcarboxylic acid derivatives
GB2090595B (en) Threo-3-amino-2-hydroxybutanoylacetice acid derivatives
ZA791109B (en) Carbamic acid derivatives
JPS54135752A (en) Nonatetraene acid derivative
JPS54100382A (en) 44pyridonee33carboxylic acid derivative
ZA792773B (en) Derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid
GB2037283B (en) -aryloxy-cyclohexylacetic acid derivatives
GB2016004B (en) U-naphthyl-acetic acid derivatives
AU5676780A (en) Benzodioxincarboxylic acid derivatives
GB2042511B (en) -lactone derivatives of 2-hydroxy-cyclopentane-carboxylic acid
GB2026485B (en) Thiopropanoylamino acid derivatives
GB2012266A (en) 1,5 - cyclohexadienecarbocylic acid derivatives
JPS5598166A (en) 66aminonicotinic acid derivative
ZA793127B (en) Novel -amino -phenylacetic acid derivatives
AU526380B2 (en) 2-isoxazoline-5-acetic acid derivatives
PH14915A (en) Citric acid derivatives
IE791075L (en) Oxofurancarboxylic acid derivatives
IE781160L (en) Piperazinecarbodithioic acid derivatives
IE780284L (en) Benzoheterocyclylglyoxylic acid derivatives
PH14278A (en) Phenoxy-phenylthioalkanecarboxylic acid derivatives
IE790880L (en) Omega-dialkylalkanoic acid derivatives
IE790710L (en) Thioetianic acid derivatives
IE780155L (en) Phenylpentanoic acid derivatives
IE780883L (en) Thiopropanoylamino acid derivatives